Likewise, the various RASopathy-like phenotypic defects related to blood clotting and hemostasis appear also to be mechanistically linked, at least in part, to the hyperactivation of KRAS signaling observed in platelets, a cellular type where KRAS regulation by microRNAs has been reported to play a relevant functional role [51]. This evidence concerns the gene KRAS and RASopathy.